Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    23269991 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Interventions: Procedure: Radiofrequency ablation;   Procedure: TACE
2 Not yet recruiting TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Surgery;   Ablation
Interventions: Procedure: TACE+RFA;   Procedure: re-resection
3 Active, not recruiting Resection+Highly Purified CTL Versus Resection Alone for HCC
Condition: Hepatocellular Carcinoma
Interventions: Procedure: resection;   Procedure: highly-purified CTL
4 Unknown  RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC
Condition: Hepatocellular Carcinoma
Interventions: Procedure: RFA;   Drug: Oxaliplatin;   Drug: 5-Fluorouracil/Leucovorin
5 Recruiting Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Hepatic resection;   Procedure: TACE;   Procedure: RFA
6 Not yet recruiting RFA Combined With Neo-MASCT for Primary HCC: a Phase II Trial
Conditions: Primary Liver Cancer;   Radiofrequency Ablation;   Immunotherapy
Intervention: Biological: Neo-MASCT

Study has passed its completion date and status has not been verified in more than two years.